课题基金 / 基金详情

Investigating Immunogenicity of Mpox and Mpox vaccine Imvamune in people living with HIV

Investigating Immunogenicity of Mpox and Mpox vaccine Imvamune in people living with HIV
研究 Mpox 和 Mpox 疫苗 Imvamune 对 HIV 感染者的免疫原性
批准号：
481131
负责人：
Costiniuk Cecilia T
金额：
$36.43万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2023
资助国家：
加拿大
项目状态：
未结题
起止时间：
2023-02-01 至 2025-02-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=481131&lang=en
关键词：
Antibodies B Cells Cell-Mediated Immunity Cytokines Epitope Mapping Hiv Immunosuppression Mpox T Cells Vaccination

项目摘要

项目成果

Costiniuk Cecilia T的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Mpox is a disease caused by a poxvirus of the same name. It is predominantly transmitted from wild animals to humans in Central and West Africa. It occurs rarely outside Africa. However, starting May 2022, Mpox outbreaks occurred in many non-African count
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of the Endocannabinoid System (ECS) in HIV-associated chronic inflammation and comorbidities
The Inaugural Symposium on Cannabis and People Living with HIV: At the Crossroads between Neuropsychology and Inflammation
The lungs as HIV reservoirs: Interplay between disrupted respiratory immunity and Chronic Obstructive Pulmonary Disease (COPD)
海外基金